Capital Raising
Blue Moon Metals Raises C$156.3 Million in Bought Deal Offerings to Advance Key Projects
Blue Moon Metals closed bought deal offerings raising C$156.3 million to fund construction and development of critical mineral projects in the U.S. and Norway.
Canamera Energy Metals Raises $10M to Accelerate Rare Earth Exploration Across Americas
Canamera Energy Metals Corp. has raised over $10 million in four months, positioning itself to expand exploration of rare earth and uranium projects in Brazil, Canada, and the USA, with multiple drill programs nearing completion.
Vivakor Secures $5 Million in Registered Direct Offering to Support Energy Infrastructure Operations
Vivakor's $5 million capital raise through a registered direct offering provides crucial working capital to support its crude oil transportation and environmental services operations across key U.S. energy basins.
C3is Inc. Completes $2 Million Capital Raise Through Registered Direct Offering
C3is Inc. has successfully closed a $2 million registered direct offering with institutional investors, providing crucial capital for general corporate purposes and working capital needs in the competitive maritime transportation sector.
Lexaria Bioscience Secures $4 Million in Capital Through Registered Direct Offering
Lexaria Bioscience Corp. has raised $4 million through a registered direct offering, providing crucial working capital to advance its DehydraTECH drug delivery platform technology.
BitFrontier Capital Holdings Engages Wellfleet Investments for Strategic Capital Raise
BitFrontier Capital Holdings has partnered with veteran investment banker Wellfleet Investments to execute a two-phase capital raise strategy aimed at funding governance reforms, acquisitions, and uplisting to OTCQB, signaling institutional validation for its turnaround plan.
Vision Marine Technologies Secures $7 Million in Public Offering to Fuel Growth Strategy
Vision Marine Technologies has successfully closed a $7 million public offering, providing crucial capital for expansion and strategic investments in the electric marine propulsion sector.
Intensity Therapeutics Raises $6.6 Million in July 2025 Through At-The-Market Stock Sales
Intensity Therapeutics, Inc. bolstered its financial position by securing $6.6 million through at-the-market stock sales, enabling further advancement of its innovative cancer therapy clinical trials.
Beeline Holdings, Inc. Strengthens Financial Position with $6.5 Million Raise and Debt Reduction
Beeline Holdings, Inc. (NASDAQ: BLNE) has bolstered its financial standing by raising $6.5 million and reducing its debt by $5.3 million, positioning the company for future growth in the digital mortgage sector.
Foremost Clean Energy Ltd. Strengthens Financial Position with $4.5 Million Raise and Extends Marketing Campaign
Foremost Clean Energy Ltd. has bolstered its financial standing by raising over $4.5 million through warrant and option exercises, supporting its uranium exploration and drilling efforts in the Athabasca Basin, while extending its investor awareness campaign to highlight its role in the nuclear energy supply chain.
Sheon Karol Joins West Lane Partners as Senior Advisor, Bringing Decades of Expertise to Middle Market Investments
Sheon Karol, a seasoned investment banker and restructuring advisor, has joined West Lane Partners as a Senior Advisor, offering his extensive experience in complex M&A, capital raises, and operational turnarounds to the firm's focus on middle market companies.
Aegis Capital Leads Super League Enterprise Public Offering, Raises Nearly $870,000
Aegis Capital Corp. has completed an underwritten public offering for Super League Enterprise, raising approximately $869,999 through the sale of 5,117,647 shares. The funding will support the company's corporate objectives and debt management strategies.
Thumzup Media Expands Shelf Registration to $500 Million, Signaling Aggressive Capital and Bitcoin Strategy
Thumzup Media Corp. has increased its universal shelf registration to $500 million, providing strategic financial flexibility to support its Bitcoin treasury approach and potential future capital needs over the next three years.
Lexaria Secures $2 Million in Direct Stock Offering Amid Challenging Market Conditions
Lexaria Bioscience has successfully closed a registered direct offering of 2 million shares at $1 per share, raising $2 million for working capital and corporate purposes without significant shareholder dilution.
Lexaria Bioscience Secures $2 Million in Registered Direct Offering
Lexaria Bioscience has entered into a definitive agreement to raise $2 million through a registered direct offering of common stock, providing capital for working capital and general corporate purposes.